Axsome Therapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2013 | — | $-2.0M | — |
| Dec 2014 | — | $-3.2M | — |
| Dec 2015 | — | $46.4M | — |
| Mar 2016 | — | $41.2M | — |
| Jun 2016 | — | $34.9M | — |
| Sep 2016 | — | $28.2M | — |
| Dec 2016 | $9.5M | $21.6M | — |
| Mar 2017 | $8.8M | $29.3M | — |
| Jun 2017 | $8.1M | $22.8M | — |
| Sep 2017 | $7.4M | $16.8M | — |
| Dec 2017 | $6.7M | $16.7M | — |
| Mar 2018 | $5.9M | $12.6M | — |
| Jun 2018 | $5.2M | $7.0M | — |
| Sep 2018 | $4.4M | $742.8K | — |
| Dec 2018 | $3.6M | $937.9K | — |
| Mar 2019 | $18.8M | $17.4M | — |
| Jun 2019 | $17.4M | $24.3M | — |
| Sep 2019 | $19.1M | $6.8M | — |
| Dec 2019 | $17.3M | $178.7M | $220.0M |
| Mar 2020 | $15.5M | $156.2M | — |
| Jun 2020 | $13.7M | $154.2M | — |
| Sep 2020 | $48.0M | $135.3M | — |
| Dec 2020 | $48.3M | $113.8M | $183.9M |
| Mar 2021 | $48.6M | $96.3M | $164.7M |
| Jun 2021 | $48.9M | $71.4M | $141.2M |
| Sep 2021 | $49.2M | $42.7M | $114.6M |
| Dec 2021 | $49.1M | $15.6M | $86.5M |
| Mar 2022 | $49.3M | $14.7M | $84.7M |
| Jun 2022 | $93.5M | $15.2M | $73.4M |
| Sep 2022 | $93.9M | $157.4M | $227.5M |
| Dec 2022 | $94.3M | $109.6M | $200.8M |
| Mar 2023 | $147.6M | $111.8M | $246.5M |
| Jun 2023 | $176.8M | $278.8M | $437.1M |
| Sep 2023 | $177.4M | $269.5M | $416.6M |
| Dec 2023 | $178.1M | $191.0M | $386.2M |
| Mar 2024 | $178.7M | $144.0M | $331.4M |
| Jun 2024 | $179.3M | $102.9M | $315.7M |
| Sep 2024 | $180.0M | $92.9M | $327.3M |
| Dec 2024 | $180.7M | $57.0M | $315.4M |
| Mar 2025 | $181.4M | $53.2M | $300.9M |
| Jun 2025 | $117.5M | $73.1M | $303.0M |
| Sep 2025 | $117.6M | $73.7M | $325.3M |
| Dec 2025 | $117.7M | $88.3M | $322.9M |
| Mar 2026 | $117.9M | $54.6M | $305.1M |
| Jun 2026 | $118.0M | $83.3M | $319.9M |